Immunity, signaling genes may be linked to schizophrenia

July 23, 2014 by Geoffrey Mohan, Los Angeles Times

The secret to schizophrenia, psychiatry's most abiding mystery, may lie in the DNA associated with the body's immune system, according to a genome-wide study published online Tuesday.

The analysis of variations in nearly 150,000 DNA samples identified 108 regions that strongly correlate with the highly heritable disorder, which is marked by psychotic episodes and cognitive deficits.

Many of the areas of DNA identified by the study either include a functioning gene or are close to one, including those previously associated with and other psychiatric disorders, according to the study published online Tuesday in the journal Nature.

Though far from producing a "smoking gun," the findings provide substantial support for a genetic root to the disorder and greatly narrow the search for genes that may cause the disease, the authors said.

"The fact that we were able to detect on this massive scale shows that schizophrenia can be tackled by the same approaches that have already transformed our understanding of other diseases," the study's senior author, Michael O'Donovan, director of the Institute of Psychological Medicine and Clinical Neurosciences at Cardiff University, said in a statement.

The most significant association involves an area on chromosome six that harbors genes associated with the cellular mechanism that flags foreign invaders so that the body's immune system can attack them. All of the anti-psychotic drugs used to treat symptoms of schizophrenia target that system, known as the major histocompatibility complex.

Other suspect areas of the genome include coding associated with signal transmission of neurons and with reception of the . Researchers have long suspected that schizophrenia is rooted in abnormal signaling involving dopamine.

The work was led by a multi-national consortium of dozens of scientists who have been investigating the roots of through genome-wide association studies, which identify variations in that are associated with disease. It was funded by the National Institute of Mental Health and Broad Institute, a biomedical research organization that partners with the Massachusetts Institute of Technology, and Harvard University and its affiliated hospitals.

The same consortium last year highlighted genetic risk factors common to autism, bipolar disorder, attention deficit hyperactivity disorder, major depression and schizophrenia. Other studies have identified about 30 areas of genetic code associated with schizophrenia.

Researchers not involved in the study praised its findings even as they cautioned that hope of a genetic key to the disease has been dashed before. Identifying an area of the genome associated with the disease is not the same as finding a specific gene, and far from identifying the biomechanical process behind the disease, said Jonathan Flint, an Oxford University geneticist who was a co-author of a separate opinion on the study in the journal Nature.

Explore further: Schizophrenia's genetic 'skyline' rising: Suspect common variants soar from 30 to 108

Related Stories

Schizophrenia's genetic 'skyline' rising: Suspect common variants soar from 30 to 108

July 21, 2014
The largest genomic dragnet of any psychiatric disorder to date has unmasked 108 chromosomal sites harboring inherited variations in the genetic code linked to schizophrenia, 83 of which had not been previously reported. ...

Gene variant linked to schizophrenia, bipolar disorder and alcoholism

July 22, 2014
A rare gene variant discovered by UCL (University College London) scientists is associated with an increased risk of developing schizophrenia, bipolar disorder and alcoholism, confirms new research.

Schizophrenia and cannabis use may share common genes

June 24, 2014
Genes that increase the risk of developing schizophrenia may also increase the likelihood of using cannabis, according to a new study led by King's College London, published today in Molecular Psychiatry.

Large study finds genetic 'overlap' between schizophrenia, bipolar disorder

September 21, 2011
Knowledge about the biological origin of diseases like schizophrenia, bipolar disorder and other psychiatric conditions is critical to improving diagnosis and treatment.

Researchers find epigenetic tie to neuropsychiatric disorders

July 21, 2014
Dysfunction in dopamine signaling profoundly changes the activity level of about 2,000 genes in the brain's prefrontal cortex and may be an underlying cause of certain complex neuropsychiatric disorders, such as schizophrenia, ...

Most powerful genetic study of psychosis to date

November 1, 2011
(Medical Xpress) -- Two genome wide studies involving more than 50,000 participants have identified new genetic risk factors for schizophrenia and bipolar disorder. The research was conducted by over 250 scientists from more ...

Recommended for you

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

Newly identified genetic marker may help detect high-risk flu patients

July 17, 2017
Researchers have discovered an inherited genetic variation that may help identify patients at elevated risk for severe, potentially fatal influenza infections. The scientists have also linked the gene variant to a mechanism ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.